dihexa cancer risk hgf c met Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cell International Hepatocyte growth factor (HGF) binding
Hepatocyte growth factor (HGF) binding c Met activates signaling Download Scientific Diagram The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is slow or c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth
Pay in 4 interest-free payments of $5.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12


